Hepatitis C, insulin resistance, and steatosis

Dawn M. Torres; Stephen A. Harrison

doi:10.1007/s11901-007-0015-6

Hepatitis C, insulin resistance, and steatosis

Dawn M. Torres, Stephen A. Harrison^*

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Chronic hepatitis C (CHC) and nonalcoholic fatty liver disease (NAFLD) are two frequently identified liver diseases worldwide. NAFLD is related to obesity and insulin resistance, which may also be a preexisting condition in patients with CHC. The complex relationship among obesity, steatosis, and insulin resistance as it pertains to the pathogenesis, treatment, and outcomes in CHC is discussed in this article.

Original language	English
Pages (from-to)	129-137
Number of pages	9
Journal	Current Hepatitis Reports
Volume	6
Issue number	4
DOIs	https://doi.org/10.1007/s11901-007-0015-6
State	Published - Nov 2007

Access to Document

10.1007/s11901-007-0015-6

Cite this

@article{c1632647809a468ba90747b66ff782b9,

title = "Hepatitis C, insulin resistance, and steatosis",

abstract = "Chronic hepatitis C (CHC) and nonalcoholic fatty liver disease (NAFLD) are two frequently identified liver diseases worldwide. NAFLD is related to obesity and insulin resistance, which may also be a preexisting condition in patients with CHC. The complex relationship among obesity, steatosis, and insulin resistance as it pertains to the pathogenesis, treatment, and outcomes in CHC is discussed in this article.",

author = "Torres, {Dawn M.} and Harrison, {Stephen A.}",

year = "2007",

month = nov,

doi = "10.1007/s11901-007-0015-6",

language = "English",

volume = "6",

pages = "129--137",

journal = "Current Hepatitis Reports",

issn = "1540-3416",

number = "4",

}

TY - JOUR

T1 - Hepatitis C, insulin resistance, and steatosis

AU - Torres, Dawn M.

AU - Harrison, Stephen A.

PY - 2007/11

Y1 - 2007/11

N2 - Chronic hepatitis C (CHC) and nonalcoholic fatty liver disease (NAFLD) are two frequently identified liver diseases worldwide. NAFLD is related to obesity and insulin resistance, which may also be a preexisting condition in patients with CHC. The complex relationship among obesity, steatosis, and insulin resistance as it pertains to the pathogenesis, treatment, and outcomes in CHC is discussed in this article.

AB - Chronic hepatitis C (CHC) and nonalcoholic fatty liver disease (NAFLD) are two frequently identified liver diseases worldwide. NAFLD is related to obesity and insulin resistance, which may also be a preexisting condition in patients with CHC. The complex relationship among obesity, steatosis, and insulin resistance as it pertains to the pathogenesis, treatment, and outcomes in CHC is discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=37049023006&partnerID=8YFLogxK

U2 - 10.1007/s11901-007-0015-6

DO - 10.1007/s11901-007-0015-6

M3 - Review article

AN - SCOPUS:37049023006

SN - 1540-3416

VL - 6

SP - 129

EP - 137

JO - Current Hepatitis Reports

JF - Current Hepatitis Reports

IS - 4

ER -

Hepatitis C, insulin resistance, and steatosis

Abstract

Access to Document

Fingerprint

Cite this